Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network -molecular docking-LC-MSE analysis

被引:38
|
作者
Zhang, Zi-jia [1 ]
Wu, Wen-yong [1 ,2 ]
Hou, Jin-jun [1 ]
Zhang, Lin-lin [1 ]
Li, Fei-fei [1 ,2 ]
Gao, Lei [1 ,2 ]
Wu, Xing-dong [1 ]
Shi, Jing-ying [1 ,2 ]
Zhang, Rong [1 ,2 ]
Long, Hua-li [1 ]
Lei, Min [1 ]
Wu, Wan-ying [1 ]
Guo, De-an [1 ]
Chen, Kai-xian [1 ]
Hofmann, Lewis A. [3 ]
Ci, Zhong-hua [3 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] World Hlth Sci Org, Leesburg, VA 20176 USA
来源
JOURNAL OF INTEGRATIVE MEDICINE-JIM | 2020年 / 18卷 / 03期
关键词
Lung-toxin Dispelling Formula No. 1; COVID-19; 3C-like protease; Network pharmacology; Molecular docking; Meridian tropism; NF-KAPPA-B; PROTEIN; DATABASE; PHARMACOLOGY; INHIBITION;
D O I
10.1016/j.joim.2020.03.004
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective: Lung-toxin Dispelling Formula No. 1, referred to as Respiratory Detox Shot (RDS), was developed based on a classical prescription of traditional Chinese medicine (TCM) and the theoretical understanding of herbal properties within TCM. Therapeutic benefits of using RDS for both disease control and prevention, in the effort to contain the coronavirus disease 2019 (COVID-19), have been shown. However, the biochemically active constituents of RDS and their mechanisms of action are still unclear. The goal of the present study is to clarify the material foundation and action mechanism of RDS. Methods: To conduct an analysis of RDS, an integrative analytical platform was constructed, including target prediction, protein-protein interaction (PPI) network, and cluster analysis; further, the hub genes involved in the disease-related pathways were identified, and the their corresponding compounds were used for in vitro validation of molecular docking predictions. The presence of these validated compounds was also measured in samples of the RDS formula to quantify the abundance of the biochemically active constituents. In our network pharmacological study, a total of 26 bioinformatic programs and databases were used, and six networks, covering the entire Zang-fu viscera, were constructed to comprehensively analyze the intricate connections among the compounds-targets-disease pathways-meridians of RDS. Results: For all 1071 known chemical constituents of the nine ingredients in RDS, identified from established TCM databases, 157 passed drug-likeness screening and led to 339 predicted targets in the constituent-target network. Forty-two hub genes with core regulatory effects were extracted from the PPI network, and 134 compounds and 29 crucial disease pathways were implicated in the target-constitu ent-disease network. Twelve disease pathways attributed to the Lung-Large Intestine meridians, with six and five attributed to the Kidney-Urinary Bladder and Stomach-Spleen meridians, respectively. One-hundred and eighteen candidate constituents showed a high binding affinity with SARS-coronavirus-2 3-chymotrypsin-like protease (3CL(pro)), as indicated by molecular docking using computational pattern recognition. The in vitro activity of 22 chemical constituents of RDS was validated using the 3CL(pro) inhibition assay. Finally, using liquid chromatography mass spectrometry in data-independent analysis mode, the presence of seven out of these 22 constituents was confirmed and validated in an aqueous decoction of RDS, using reference standards in both non-targeted and targeted approaches. Conclusion: RDS acts primarily in the Lung-Large Intestine, Kidney-Urinary Bladder and Stomach-Spleen meridians, with other Zang-fu viscera strategically covered by all nine ingredients. In the context of TCM meridian theory, the multiple components and targets of RDS contribute to RDS's dual effects of health-strengthening and pathogen-eliminating. This results in general therapeutic effects for early COVID-19 control and prevention. (C) 2020 Shanghai Changhai Hospital. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:229 / 241
页数:13
相关论文
共 33 条
  • [21] Advances of Traditional Chinese Medicine in therapy for COVID-19 based on effective compounds identification and therapeutic mechanisms analysis
    Li, Yuan
    Yao, Li
    Chinese Journal of Analysis Laboratory, 2021, 40 (07) : 784 - 791
  • [22] Traditional Chinese medicine for symptoms of upper respiratory tract of COVID-19 A protocol for systematic review and meta-analysis
    Liang, Fangqi
    Dong, Lei
    Zhou, Li
    Shi, Yu
    Tian, Li
    MEDICINE, 2020, 99 (30) : E21320
  • [23] Analysis of the Active Components and Mechanism of Three Prescriptions in the Treatment of COVID-19 Via Network Pharmacology and Molecular Docking
    Wang, Fei
    Chen, Jia-Hui
    Liu, Bo
    Zhang, Ting
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (09)
  • [24] Integrated network pharmacology analysis, molecular docking, LC-MS analysis and bioassays revealed the potential active ingredients and underlying mechanism of Scutellariae radix for COVID-19
    Liu, Jiazheng
    Meng, Jieru
    Li, Runfeng
    Jiang, Haiming
    Fu, Lu
    Xu, Ting
    Zhu, Guo-Yuan
    Zhang, Wei
    Gao, Jin
    Jiang, Zhi-Hong
    Yang, Zi-Feng
    Bai, Li-Ping
    FRONTIERS IN PLANT SCIENCE, 2022, 13
  • [25] Oral traditional Chinese medicine for mild to moderate cases of COVID-19: a network meta-analysis based on RCTs
    Cao, Wen
    He, Nannan
    Luo, Yannian
    Zhang, Zhiming
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (11):
  • [26] Traditional Chinese medicine as an adjunctive therapy for mild and common COVID-19 A systematic review and network meta-analysis
    Wu, Xiaozheng
    Li, Wen
    Qin, Zhong
    Xue, Lei
    Huang, Gao
    Luo, Zhenliang
    Chen, Yunzhi
    MEDICINE, 2021, 100 (40) : E27372
  • [27] Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking
    Simayi, Jimilihan
    Nuermaimaiti, Maimaitiming
    Wumaier, Ainiwaer
    Khan, Nawaz
    Yusufu, Maierdan
    Nuer, Muhadaisi
    Maihemuti, Nulibiya
    Bayinsang
    Adurusul, Kaysar
    Zhou, Wenting
    MEDICINE, 2022, 101 (01) : E28286
  • [28] The influence of changes in the Chinese COVID-19 prevention and control policies on mental health of medical staff: A network analysis
    Zhang, Yuqun
    Luo, Meiyan
    Ouyang, Jian
    Chen, Ying
    Xia, Haozhi
    Yang, Fan
    Wu, Tao
    Yin, Chan
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 335 : 10 - 17
  • [29] Efficacy and safety of traditional Chinese medicine combined with routine western medicine for the asymptomatic novel coronavirus disease (COVID-19) A Bayesian network meta-analysis protocol
    Wang, Jiahao
    Zhu, Xue
    Sun, Yuying
    Zhang, Xingcai
    Zhang, Wei
    MEDICINE, 2020, 99 (35)
  • [30] Identification of active compounds of traditional chinese medicine derived from maxing shigan decoction for COVID-19 treatment: a meta-analysis and in silico study
    Guo, Xiaodan
    Lin, Yihua
    He, Fengming
    Jin, Ying
    Chen, Simian
    Li, Ting
    Wu, Caisheng
    Zhang, Lin
    Chen, Xueqin
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (08) : 871 - 889